Thursday, Aug 18, 2022
English News
  • Hyderabad
  • Telangana
  • Andhra Pradesh
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Reviews
    • Education Today
    • Property
    • Videos
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
Home | India | Zydus Commences Supply Of Covid 19 Vaccine Zycov D To Central Govt

Zydus commences supply of COVID-19 vaccine ZyCoV-D to Central govt

By ANI
Published: Published Date - 11:04 AM, Wed - 2 February 22
Zydus commences supply of COVID-19 vaccine ZyCoV-D to Central govt

Ahmedabad: Pharmaceutical company Zydus on Wednesday announced that it has started the supplies of its COVID-19 vaccine ZyCoV-D to the Government of India against their order from its newly commissioned state-of-the-art, Zydus Vaccine Technology Excellence Centre at the Zydus Biotech Park in Changodar, Ahmedabad.

The company is also planning to make the vaccine available in the private market.
ZyCoV-D is a three-dose vaccine administered intradermally using the painless PharmaJet(r) needle-free system, Tropis(r), on day 0, day 28 and day 56.

The vaccine will be priced at Rs 265 per dose and the applicator being offered at Rs 93 per dose excluding GST Zydus VTEC manufactures the drug substance for the needle-free DNA Plasmid vaccine, ZyCoV-D. The manufacturing process and in-process material transfers within the plant are automated.

Zydus has also entered into a definitive agreement with Shilpa Medicare Limited, a contract manufacturing organization to produce mutually agreeable doses of ZyCoV-D.
The company also entered into an agreement with Enzychem Lifesciences of the Republic of Korea for the manufacturing license and technology transfer for the Plasmid DNA Vaccine.

  • Follow Us :
  • Tags
  • Enzychem Lifesciences
  • GST Zydus VTEC
  • Zydus

Related News

  • Zydus’ Virafin gets emergency use approval for treating moderate COVID-19 cases

    Zydus’ Virafin gets emergency use approval for treating moderate COVID-19 cases

  • Indian drug firms recall various products in US market

    Indian drug firms recall various products in US market

Latest News

  • Opinion: Focus on quality of education

    1 hour ago
  • Editorial: Travesty of justice

    1 hour ago
  • Rape accused who escaped from police custody beaten to death in Assam

    1 hour ago
  • New Omicron variants fuel demand for update of Covid vaccines

    2 hours ago
  • Ratio and proportion made easier

    2 hours ago
  • Telangana can’t buy, sell power: Centre

    2 hours ago
  • Candidates won’t be allowed for PWT even if late by a minute

    2 hours ago
  • Docs got Rs 1,000 crore worth freebies for prescribing Dolo

    2 hours ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam